AbbVie Humera®, a Biotech Product worth 22.2 Billion USD, the highest gross-selling drug in the world

HUMERA

AbbVie is a global biopharmaceutical research-based company focused on the development of innovative, advanced therapies that address some of the world’s most complex and serious diseases in four major therapeutic areas: immunology, oncology, virology and neuroscience. Rather than investing heavily in research and development to find new drugs, AbbVie believes that it is easier and … Read more AbbVie Humera®, a Biotech Product worth 22.2 Billion USD, the highest gross-selling drug in the world

Open chat
Powered by